These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 27797221)
1. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas. Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221 [TBL] [Abstract][Full Text] [Related]
2. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma]. Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma. He Z; Yi J; Jin L; Pan B; Chen L; Song H Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958 [TBL] [Abstract][Full Text] [Related]
4. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma. Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660 [TBL] [Abstract][Full Text] [Related]
5. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma. Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281 [TBL] [Abstract][Full Text] [Related]
6. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition. Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143 [TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma. Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690 [TBL] [Abstract][Full Text] [Related]
8. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus. Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554 [TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma. Li K; Wang RW; Jiang YG; Zou YB; Guo W Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694 [TBL] [Abstract][Full Text] [Related]
12. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance]. Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma. Zhang H; Chen W; Duan CJ; Zhang CF World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267 [TBL] [Abstract][Full Text] [Related]
14. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Shibata H; Matsubara O; Wakiyama H; Tanaka S Pathol Res Pract; 2001; 197(3):157-64. PubMed ID: 11314778 [TBL] [Abstract][Full Text] [Related]
15. CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma. Sato Y; Motoyama S; Nanjo H; Wakita A; Yoshino K; Sasaki T; Nagaki Y; Liu J; Imai K; Saito H; Minamiya Y Ann Surg Oncol; 2016 Mar; 23(3):936-42. PubMed ID: 26464192 [TBL] [Abstract][Full Text] [Related]
16. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792 [TBL] [Abstract][Full Text] [Related]
17. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969 [TBL] [Abstract][Full Text] [Related]
18. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206 [TBL] [Abstract][Full Text] [Related]
19. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995 [TBL] [Abstract][Full Text] [Related]
20. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis]. Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]